More on CATX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.2 Score)

Upcoming Events

- Earnings (8/18/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Perspective Therapeutics (NY:CATX)
Delayed: 2.99 +0.04 (1.36%)
Prev. Close $2.95  
Open$2.93 
52 Wk High$ 
52 Wk Low$ 
Day High$3.01 
Day Low$2.88 
P/E N/A  
EPS$ 
Volume1,003,836 

Friends, Peers and Foes (?): BCYC, IDYA, ACAD, BCRX, CDTX (more...)

Jul 17, 2026 12:22 PM Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Oral Presentation at the ESMO Congress 2026
Jul 8, 2026 06:33 AM Perspective Therapeutics names new chief science officer
Jul 1, 2026 04:11 PM Form 8-K Perspective Therapeutics For: Jul 01
Jun 30, 2026 05:37 PM Form SCHEDULE 13G Perspective Therapeutics Filed by: MILLENNIUM MANAGEMENT LLC
Jun 1, 2026 06:31 AM Form 8-K Perspective Therapeutics For: Jun 01
May 27, 2026 04:20 PM Form 8-K Perspective Therapeutics For: May 27
May 22, 2026 06:01 AM Form 8-K Perspective Therapeutics For: May 21
May 21, 2026 05:51 PM Perspective Therapeutics to Present Data from All Clinical Programs at the 2026 ASCO Annual Meeting, including Findings from [212Pb]VMT01 in Melanoma
May 18, 2026 06:30 AM Perspective Therapeutics doses first patients in new study cohorts
May 18, 2026 06:30 AM Perspective Therapeutics Announces First Patients Dosed in New Cohorts of Two Ongoing Phase 1/2a Studies
View All Articles

Entities mentioned with CATX

View All Entities